116 related articles for article (PubMed ID: 19952434)
1. Hepatic contribution to a marked increase in the plasma concentration of baicalin after oral administration of its aglycone, baicalein, in multidrug resistance-associated protein 2-deficient rat.
Akao T; Sato K; Hanada M
Biol Pharm Bull; 2009 Dec; 32(12):2079-82. PubMed ID: 19952434
[TBL] [Abstract][Full Text] [Related]
2. Baicalein 6-O-β-D-glucopyranuronoside is a main metabolite in the plasma after oral administration of baicalin, a flavone glucuronide of scutellariae radix, to rats.
Akao T; Sato K; He JX; Ma CM; Hattori M
Biol Pharm Bull; 2013; 36(5):748-53. PubMed ID: 23649334
[TBL] [Abstract][Full Text] [Related]
3. Enteric excretion of baicalein, a flavone of Scutellariae Radix, via glucuronidation in rat: involvement of multidrug resistance-associated protein 2.
Akao T; Sakashita Y; Hanada M; Goto H; Shimada Y; Terasawa K
Pharm Res; 2004 Nov; 21(11):2120-6. PubMed ID: 15587936
[TBL] [Abstract][Full Text] [Related]
4. Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats.
Lai MY; Hsiu SL; Tsai SY; Hou YC; Chao PD
J Pharm Pharmacol; 2003 Feb; 55(2):205-9. PubMed ID: 12631413
[TBL] [Abstract][Full Text] [Related]
5. Oral pharmacokinetics of baicalin, wogonoside, oroxylin A 7-O-β-d-glucuronide and their aglycones from an aqueous extract of Scutellariae Radix in the rat.
Cai Y; Li S; Li T; Zhou R; Wai AT; Yan R
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():124-133. PubMed ID: 26809374
[TBL] [Abstract][Full Text] [Related]
6. Biliary excretion of curcumin is mediated by multidrug resistance-associated protein 2.
Lee JH; Oh JH; Lee YJ
Biol Pharm Bull; 2012; 35(5):777-80. PubMed ID: 22687416
[TBL] [Abstract][Full Text] [Related]
7. Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form.
Akao T; Kawabata K; Yanagisawa E; Ishihara K; Mizuhara Y; Wakui Y; Sakashita Y; Kobashi K
J Pharm Pharmacol; 2000 Dec; 52(12):1563-8. PubMed ID: 11197087
[TBL] [Abstract][Full Text] [Related]
8. Sinusoidal efflux of taurocholate is enhanced in Mrp2-deficient rat liver.
Akita H; Suzuki H; Sugiyama Y
Pharm Res; 2001 Aug; 18(8):1119-25. PubMed ID: 11587482
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of flavonoids from xiexin decoction in rats].
Yan JC; Liu ZM; Wang TM; Shi R; Ma YM
Yao Xue Xue Bao; 2007 Jul; 42(7):722-9. PubMed ID: 17882955
[TBL] [Abstract][Full Text] [Related]
10. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
11. Mrp2 is involved in benzylpenicillin-induced choleresis.
Ito K; Koresawa T; Nakano K; Horie T
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G42-9. PubMed ID: 15194559
[TBL] [Abstract][Full Text] [Related]
12. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2.
Johnson DR; Habeebu SS; Klaassen CD
Toxicol Sci; 2002 Mar; 66(1):16-26. PubMed ID: 11861969
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats.
Moriwaki T; Yasui H; Yamamoto A
Pharm Res; 2004 Jun; 21(6):1055-64. PubMed ID: 15212172
[TBL] [Abstract][Full Text] [Related]
14. Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco-2 cells through multidrug resistance-associated protein 2.
Akao T; Hanada M; Sakashita Y; Sato K; Morita M; Imanaka T
J Pharm Pharmacol; 2007 Jan; 59(1):87-93. PubMed ID: 17227625
[TBL] [Abstract][Full Text] [Related]
15. Impact of Mrp2 on the biliary excretion and intestinal absorption of furosemide, probenecid, and methotrexate using Eisai hyperbilirubinemic rats.
Chen C; Scott D; Hanson E; Franco J; Berryman E; Volberg M; Liu X
Pharm Res; 2003 Jan; 20(1):31-7. PubMed ID: 12608533
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.
Hirouchi M; Suzuki H; Sugiyama Y
Pharm Res; 2005 Apr; 22(4):661-6. PubMed ID: 15846474
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective hepatic disposition of a diastereomeric pair of alphavbeta3 antagonists in rat.
Prueksaritanont T; Xu X; Deluna P; Yamazaki M; Lin JH
Xenobiotica; 2003 Nov; 33(11):1125-37. PubMed ID: 14660176
[TBL] [Abstract][Full Text] [Related]
18. Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.
Takenaka O; Horie T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1995 Sep; 274(3):1362-9. PubMed ID: 7562509
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
[TBL] [Abstract][Full Text] [Related]
20. Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract.
Xing J; Chen X; Sun Y; Luan Y; Zhong D
J Pharm Pharmacol; 2005 Jun; 57(6):743-50. PubMed ID: 15969929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
